A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to evaluate the effects of various doses of nebivolol in patients with mild to moderate hypertension.
Full description
This was a multi-center, randomized, double-blind, parallel group, placebo-controlled study of nebivolol over a range of doses in patients with mild to moderate hypertension. The study consisted of 2 phases: screening/washout/single-blind placebo run-in followed by randomization/double-blind treatment. During the double-blind phase, patients received nebivolol or placebo. Patients had 7 scheduled clinical visits during the study.
Sex
Ages
Volunteers
Inclusion criteria
- An average sitting diastolic blood pressure of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline
Exclusion criteria
- Recent myocardial infarction or stroke
- Secondary hypertension
- Contraindications to beta-blocker treatment or discontinuation of current antihypertensive therapy
- Pregnancy, nursing, or women of child-bearing potential not using appropriate contraception
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal